Advertisement
Loading...

Elanco Animal Health Incorporated

ELANNYSE
Healthcare
Drug Manufacturers - Specialty & Generic
$19.86
$-1.78(-8.23%)
U.S. Market opens in 28h 24m

Elanco Animal Health Incorporated (ELAN) Stock Overview

Explore Elanco Animal Health Incorporated’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap9.9B
P/E Ratio-41.41
EPS (TTM)$-0.50
ROE-0.04%
Fundamental Analysis

AI Price Forecasts

1 Month$23.99
3 Months$30.26
1 Year Target$30.54

ELAN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Elanco Animal Health Incorporated (ELAN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 35.77, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $30.54.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -41.41 and a market capitalization of 9.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-8.25%
5-Day Change
-17.82%
1-Month Change
-14.53%
3-Month Change
-20.99%
6-Month Change
-5.86%
Year-to-Date (YTD) Change
-12.26%
1-Year Change
53.44%
3-Year Change
123.09%
5-Year Change
-43.29%
All-Time (Max) Change
-44.85%

Contact Information

877 352 6261
2500 Innovation Way, Greenfield, IN, 46140

Company Facts

9,000 Employees
IPO DateSep 20, 2018
CountryUS
Actively Trading

Frequently Asked Questions